je.st
news
FDA Declines To Expand Approval Of Pfizer Arthritis Drug
2015-10-15 19:03:30| Biotech - Topix.net
U.S. health regulators declined to approve Pfizer Inc's oral rheumatoid arthritis drug Xeljanz to treat moderate to severe cases of the scaly skin condition plaque psoriasis, the drugmaker said on Wednesday. Pfizer said it received a so-called complete response letter from the Food and Drug Administration.
Tags: expand
drug
approval
arthritis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||